Comparison of neuromuscular blockade's monitoring and clinical assessment during cisatracurium paralysis in critically ill patients

Trial Profile

Comparison of neuromuscular blockade's monitoring and clinical assessment during cisatracurium paralysis in critically ill patients

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Apr 2016

At a glance

  • Drugs Cisatracurium besilate (Primary)
  • Indications Muscle hypertonia
  • Focus Therapeutic Use
  • Acronyms MONITOR
  • Most Recent Events

    • 27 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top